GHU Logo
The Great Heights University Library
Academic discovery, digital access, and research support

Cancer Nanotechnology (Record no. 8545)

MARC details
000 -LEADER
fixed length control field 05345nam a22005295i 4500
001 - CONTROL NUMBER
control field 978-1-60761-609-2
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20260610083722.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 100316s2010 xxu| s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781607616092
-- 978-1-60761-609-2
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-1-60761-609-2
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC254-282
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED062000
Source bisacsh
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source thema
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 616.994
Edition information 23
245 10 - TITLE STATEMENT
Title Cancer Nanotechnology
Medium [electronic resource] :
Remainder of title Methods and Protocols /
Statement of responsibility, etc. edited by Stephen R. Grobmyer, Brij M. Moudgil.
250 ## - EDITION STATEMENT
Edition statement 1st ed. 2010.
264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Place of production, publication, distribution, manufacture Totowa, NJ :
Name of producer, publisher, distributor, manufacturer Humana Press :
-- Imprint: Humana,
Date of production, publication, distribution, manufacture, or copyright notice 2010.
300 ## - online resource
Extent XIII, 396 p.
Other physical details online resource.
336 ## - CONTENT TYPE
Content type term text
Content type code txt
Source rdacontent
337 ## - MEDIA TYPE
Media type term computer
Media type code c
Source rdamedia
338 ## - CARRIER TYPE
Carrier type term online resource
Carrier type code cr
Source rdacarrier
347 ## - DIGITAL FILE CHARACTERISTICS
File type text file
Encoding format PDF
Source rda
490 1# - SERIES STATEMENT
Series statement Methods in Molecular Biology,
International Standard Serial Number 1940-6029 ;
Volume/sequential designation 624
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note What Is Cancer Nanotechnology? -- Molecular-Targeted Therapy for Cancer and Nanotechnology -- Enhanced Permeability and Retention (EPR) Effect for Anticancer Nanomedicine Drug Targeting -- Nanoparticle Characterization for Cancer Nanotechnology and Other Biological Applications -- Multimodal Nanoparticulate Bioimaging Contrast Agents -- Gold Nanocages for Cancer Imaging and Therapy -- Nanoshells for Photothermal Cancer Therapy -- Gold Nanorods: Multifunctional Agents for Cancer Imaging and Therapy -- Polymeric Micelles: Polyethylene Glycol-Phosphatidylethanolamine (PEG-PE)-Based Micelles as an Example -- Fluorescent Silica Nanoparticles for Cancer Imaging -- Polymeric Nanoparticles for Drug Delivery -- Synthesis, Characterization, and Functionalization of Gold Nanoparticles for Cancer Imaging -- Identification of Pancreatic Cancer-Specific Cell-Surface Markers for Development of Targeting Ligands -- Preparation and Characterization of Doxorubicin Liposomes -- PEGylated Nanocarriers for Systemic Delivery -- Nanoparticle–Aptamer Conjugates for Cancer Cell Targeting and Detection -- Targeting of Nanoparticles: Folate Receptor -- Magnetic Aerosol Targeting of Nanoparticles to Cancer: Nanomagnetosols -- LHRH-Targeted Nanoparticles for Cancer Therapeutics -- Antibody Targeting of Nanoparticles to Tumor-Specific Receptors: Immunoliposomes -- Photoacoustic Tomography for Imaging Nanoparticles -- Current Applications of Nanotechnology for Magnetic Resonance Imaging of Apoptosis -- Applications of Gold Nanorods for Cancer Imaging and Photothermal Therapy -- Use of Nanoparticles for Targeted, Noninvasive Thermal Destruction of Malignant Cells -- Colloidal Gold: A Novel Nanoparticle for Targeted Cancer Therapeutics -- Liposomal Doxorubicin and nab-Paclitaxel: Nanoparticle Cancer Chemotherapy in CurrentClinical Use.
520 ## - SUMMARY, ETC.
Summary, etc. Early detection of cancer at the cellular level, even before anatomic anomalies are visible, is critical to more efficacious and cost effective diagnosis and therapeutic advances. In Cancer Nanotechnology: Methods and Protocols, an international panel of experts provide the most recent, cutting-edge, "how-to" approaches developed and employed by researchers in a variety of disciplines to identify cancer specific biomarkers, construct suitable multifunctional targeted nanostructure platforms, along with enhanced imaging and therapeutic applications. Covering such topics as multifunctional and multimodal nanoparticles, nanoparticle mediated cancer theranostics, molecular targets for cancer nanotechnology, and nanoparticles for non-invasive image-guided cancer therapy, the volume addresses the key challenges of the field today, specifically targeted and localized delivery of the drugs. As a volume in the highly successful Methods in Molecular Biologyâ„¢ series, the protocols chapters include brief introductions to their respective topics, lists of the necessary materials and reagents, step-by-step, readily reproducible laboratory protocols, and notes on troubleshooting and avoiding known pitfalls. Authoritative and cutting-edge, Cancer Nanotechnology: Methods and Protocols integrates cancer biology, clinical oncology, molecular cancer imaging, materials science and chemical engineering, biomedical engineering, toxicology, computer science, electrical engineering, chemistry, physics, and mathematics in order to achieve the vital goals of nanotechnology-mediated early cancer detection and more efficacious and less toxic therapies for these devastating diseases.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Medicine
General subdivision Research.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biology
General subdivision Research.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Cancer Biology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomedical Research.
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Grobmyer, Stephen R.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Moudgil, Brij M.
Relator term editor.
Relationship edt
-- http://id.loc.gov/vocabulary/relators/edt
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer Nature eBook
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781607616085
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781607616139
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Relationship information Printed edition:
International Standard Book Number 9781493961207
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Methods in Molecular Biology,
International Standard Serial Number 1940-6029 ;
Volume/sequential designation 624
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/978-1-60761-609-2">https://doi.org/10.1007/978-1-60761-609-2</a>
912 ## -
-- ZDB-2-PRO

No items available.